The Connecticut General Assembly’s only bipartisan committee voted June 2 to add chronic pain and Ehlers-Danlos Syndrome to the state’s medical cannabis program, according to a CTPost report.
The Regulation Review Committee’s vote comes eight months after a panel of physicians recommended adding the conditions to the program, according to the news outlet, and brings the total number of qualifying conditions for adults to 38, while there are 10 qualifying conditions for children under the age of 18.
Now, the Department of Consumer Protection, which oversees Connecticut’s medical cannabis program, must submit the new conditions to the Secretary of State’s Office, which will post the final regulations online, CTPost reported.
The state’s medical cannabis program has been operational for eight years, and 41,292 patients and 1,270 physicians are currently enrolled, according to the news outlet.
